Form 8-K - Current report:
SEC Accession No. 0001655759-25-000095
Filing Date
2025-06-02
Accepted
2025-06-02 06:12:38
Documents
19
Period of Report
2025-05-31
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arvn-20250531.htm   iXBRL 8-K 44288
2 EX-99.1 veritac2_asco2025xpressr.htm EX-99.1 24438
6 veritac2_asco2025xpressr001.jpg GRAPHIC 253717
7 veritac2_asco2025xpressr002.jpg GRAPHIC 319633
8 veritac2_asco2025xpressr003.jpg GRAPHIC 274904
9 veritac2_asco2025xpressr004.jpg GRAPHIC 332673
10 veritac2_asco2025xpressr005.jpg GRAPHIC 339392
11 veritac2_asco2025xpressr006.jpg GRAPHIC 164732
  Complete submission text file 0001655759-25-000095.txt   2526191

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20250531.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20250531_lab.xml EX-101.LAB 23451
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20250531_pre.xml EX-101.PRE 13581
21 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20250531_htm.xml XML 2816
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 251013043
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)